Aharon Schwartz - Net Worth and Insider Trading
Aharon Schwartz Net Worth
The estimated net worth of Aharon Schwartz is at least $214,020 dollars as of 2024-11-07. Aharon Schwartz is the Director of Protalix BioTherapeutics Inc and owns about 174,000 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $214,020. Details can be seen in Aharon Schwartz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aharon Schwartz has not made any transactions after 2023-01-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aharon Schwartz
Aharon Schwartz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aharon Schwartz owns 2 companies in total, including Protalix BioTherapeutics Inc (PLX) , and Foamix Pharmaceuticals Ltd (FOMX) .
Click here to see the complete history of Aharon Schwartz’s form 4 insider trades.
Insider Ownership Summary of Aharon Schwartz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2023-01-03 | director |
| FOMX | Foamix Pharmaceuticals Ltd | 2020-03-09 | director |
Aharon Schwartz Latest Holdings Summary
Aharon Schwartz currently owns a total of 1 stock. Aharon Schwartz owns 174,000 shares of Protalix BioTherapeutics Inc (PLX) as of January 3, 2023, with a value of $214,020.
Latest Holdings of Aharon Schwartz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2023-01-03 | 174,000 | 1.23 | 214,020 |
Holding Weightings of Aharon Schwartz
Aharon Schwartz Form 4 Trading Tracker
According to the SEC Form 4 filings, Aharon Schwartz has made a total of 2 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 110,000 shares on January 3, 2023, which cost Aharon Schwartz around $156,200.
Insider Trading History of Aharon Schwartz
- 1
Aharon Schwartz Trading Performance
GuruFocus tracks the stock performance after each of Aharon Schwartz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aharon Schwartz is 55.66%. GuruFocus also compares Aharon Schwartz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aharon Schwartz within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aharon Schwartz's insider trading performs compared to the benchmark.
Performance of Aharon Schwartz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.5 | | | | | |
| Relative Return to S&P 500(%) | 15.25 | | | | | |
Aharon Schwartz Ownership Network
Ownership Network List of Aharon Schwartz
Ownership Network Relation of Aharon Schwartz
Aharon Schwartz Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Aharon Schwartz is the director of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Aharon Schwartz made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 64,516 shares made by Dror Bashan ,
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 64,516 shares were bought by its insiders, resulting in a net purchase of 64,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Aharon Schwartz Mailing Address
Above is the net worth, insider trading, and ownership report for Aharon Schwartz. You might contact Aharon Schwartz via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit Street, Science Park, #455, Carmiel L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
